vegetable (canola, flaxseed) derived n-3 fatty acid
Dietary Supplementvegetable (canola, flaxseed) derived n-3 fatty acid was used for fat source.
NCT Number: NCT03638661
The aim of our study was to investigate the NK cell activity alternations and related cytokine changes in comparison with soybean oil used formula (control) and the canola and flaxseed oil used n-3 fatty acid enriched formula (n3EN, test) with non-surgical hospitalized patients for rehabilitation.
Looking for future studies?
Notify Me19 year–100 year
All sexes
Interventional
Not applicable
Patients were randomized to receive one of two types of enteral nutrition formula: soybean oil used enteral nutrition (control), vegetable (canola, flaxseed) derived n-3 fatty acid enriched enteral nutrition (n3EN). Blood samples were collected on the first day and 14 days after consumption of each formula and anthropometric parameters were collected. Hematology and biochemical values were analyzed and NK cell activities and serum cytokine productions were measured.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
vegetable (canola, flaxseed) derived n-3 fatty acid was used for fat source.
soybean oil used formula
Time frame: Baseline
NK cell activity (%)
Time frame: Baseline
(IL-12, IFN-γ, IL-1β , IL-6 and TNF-α)
Yonsei University
Other
Effect of Immune-enhancing Enteral Nutrition Formula Enriched With Vegetable Derived n-3 Fatty Acids on NK Cell Activity in Hospitalized Patients for Rehabilitation
Acronym: YS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07437352
Enteral Nutrition, Frailty
Ancona, Italy
View Trial DetailsNCT07131098
Critical Illness, Disease Attributes
Jenin, Palestinian Territories
View Trial DetailsNCT06239610
Enteral Nutrition
Fort Wayne, Indiana, United States
View Trial DetailsNCT07018414
Abdominal Distension, Critical Illness
Istanbul, İ̇stanbul, Turkey (Türkiye)
View Trial Details